Novo CEO pressed by Senate to cut costs of weight problems, diabetes prescription drugs CEO Lars Fruergaard Jørgensen advised lawmakers the company would consider new talks with insurers concerning the listing price ranges of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. This https://label-the-figure-with-the74062.blog5.net/73081551/healthcare-news-an-overview